论文部分内容阅读
目的:观察84例高血压合并糖尿病患者的临床治疗。方法:选取2015年2月—2016年2月我院收治的84例高血压合并糖尿病患者作为观察对象,随机分为2组,各42例;对照组患者单用缬沙坦胶囊(代文)治疗,观察组患者给予缬沙坦胶囊(代文)联合苯磺酸左旋氨氯地平片(施慧达)治疗,对比两组患者治疗效果。结果:观察组患者的治疗总有效率为95.24%,明显高于对照组69.05%,两组数据差异有统计学意义(P<0.05);观察组患者的空腹血糖指数明显低于对照组,两组数据差异有统计学意义(P<0.05)。结论:高血压合并糖尿病患者的给予缬沙坦胶囊(代文)联合苯磺酸左旋氨氯地平片(施慧达)治疗效果良好,值得推广及使用。
Objective: To observe the clinical treatment of 84 patients with hypertension and diabetes mellitus. Methods: Totally 84 hypertensive patients with diabetes mellitus admitted to our hospital from February 2015 to February 2016 were randomly divided into 2 groups (n = 42). Patients in the control group were treated with valsartan capsules Patients in the treatment group and the observation group were treated with valsartan capsules (Soprano) combined with levamlodipine besylate (Shihui Da), and the treatment effect was compared between the two groups. Results: The total effective rate of the observation group was 95.24%, which was significantly higher than that of the control group (69.05%), the difference between the two groups was statistically significant (P <0.05); the fasting blood glucose index of the observation group was significantly lower than that of the control group There was significant difference between groups (P <0.05). CONCLUSIONS: Valsartan capsules combined with diabetes patients treated with L-amlodipine besylate are effective and worthy of promotion and use.